BRYAN BURT to Combined Modality Therapy
This is a "connection" page, showing publications BRYAN BURT has written about Combined Modality Therapy.
Connection Strength
0.247
-
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
Score: 0.110
-
Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014 Feb; 41(1):40-56.
Score: 0.081
-
Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Jan; 113(1):279-285.
Score: 0.033
-
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol. 2005 Dec 01; 23(34):8713-6.
Score: 0.012
-
Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). FASEB J. 2004 Jun; 18(9):1001-3.
Score: 0.010